Followers | 194 |
Posts | 24510 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Thursday, June 04, 2020 11:57:06 AM
You do a fantastic job of pretending you are outside of left and right while spinning out right-wing talking points. This is a thing. It’s fantastic.
You’re really great at this stuff. Good luck with that.
In this instance, you made two random Italian scientists quoted in an obscure Reuter’s report the end all and be all of scientific evidence and used Chompsky to justify it while again suggesting you are consistent with the greatest traditions of science and that Chompsky would give the seal of approval on these very adept mental hijinx and endorse the manufactured consent of the scientific establishment, but careful not to state the argument that way. Very adept!
In the other story, the Chloroquine story, there are multiple studies, all saying the same thing, but I do not disagree that the further investigation of the one study might be worthwhile. It should be certain. If there were any major and truly discrediting issues with the evidence in the study, how it was run or reported, anyone would want to know that, even the scientific establishment. I don’t necessarily believe there is a conspiracy or any attempt to “manufacture consent” at some mysterious Q level. But if there is something to the study having flaws, I’m open minded enough to consider it. I simply want science, not nonsense and conspiracy theories driving the conversations and decisions, at the highest level.
Good luck!
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM